JANUS HENDERSON GROUP PLC

Holdings History for Akero Therapeutics, Inc. - Common Stock (AKRO)

Symbol: AKRO on Nasdaq
Investment type: Equity - Shares of Stock
Class: Common Stock
Latest Disclosed Ownership: 6.03M shares
Security Ownership: 8.7%

Shares, Excluding Options vs Price

Value, Excluding Options

JANUS HENDERSON GROUP PLC ownership in Akero Therapeutics, Inc. Common Stock (AKRO)

2025-02-14 - JANUS HENDERSON GROUP PLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 6.03M shares of Akero Therapeutics, Inc. Common Stock (AKRO). This represents 8.7% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
JANUS HENDERSON GROUP PLC	8.7%		$244M	6.03M			$40.48	13G/A	12/31/2024	14 Feb 2025 12:58:08

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
12/31/2024	0.09%	-0.01%	$168M	6.03M	-1,043,239	-14.7%	$27.80	Q4 2024
9/30/2024	0.1%	+0%	$203M	7.08M	+201,225	+2.93%	$28.69	Q3 2024
6/30/2024	0.09%	+0.01%	$161M	6.88M	+754,283	+12.3%	$23.45	Q2 2024
3/31/2024	0.08%	+0.03%	$155M	6.12M	+1,815,569	+42.2%	$25.25	Q1 2024
12/31/2023	0.06%	0%	$101M	4.31M	-180,325	-4.02%	$23.35	Q4 2023
9/30/2023	0.15%	+0%	$227M	4.49M	+61,607	+1.39%	$50.58	Q3 2023
6/30/2023	0.13%	+0.02%	$207M	4.43M	+613,443	+16.1%	$46.69	Q2 2023
3/31/2023	0.1%	+0.01%	$146M	3.81M	+471,502	+14.1%	$38.26	Q1 2023
12/31/2022	0.13%	-0.04%	$183M	3.34M	-935,285	-21.9%	$54.80	Q4 2022
9/30/2022	0.11%	+0.03%	$146M	4.28M	+1,207,147	+39.3%	$34.05	Q3 2022
6/30/2022	0.02%	0%	$29M	3.07M	-300,350	-8.92%	$9.45	Q2 2022
3/31/2022	0.02%	+0%	$47.8M	3.37M	+205,040	+6.48%	$14.19	Q1 2022
12/31/2021	0.03%	0%	$66.9M	3.16M	-71,365	-2.21%	$21.15	Q4 2021
9/30/2021	0.03%	0%	$72.3M	3.23M	-252,508	-7.24%	$22.35	Q3 2021
6/30/2021	0.04%	+0%	$86.5M	3.49M	+4,830	+0.14%	$24.81	Q2 2021
3/31/2021	0.05%	0%	$101M	3.48M	-10,754	-0.31%	$29.01	Q1 2021
12/31/2020	0.04%	0%	$90.1M	3.49M	-42,036	-1.19%	$25.80	Q4 2020
9/30/2020	0.06%	+0.01%	$109M	3.54M	+796,937	+29.1%	$30.79	Q3 2020
6/30/2020	0.04%	0%	$68.2M	2.74M	-28,302	-1.02%	$24.92	Q2 2020
3/31/2020	0.04%	+0.01%	$58.7M	2.77M	+357,287	+14.8%	$21.20	Q1 2020
12/31/2019	0.03%	+0%	$53.5M	2.41M	+379,505	+18.7%	$22.19	Q4 2019
9/30/2019	0.02%	+0.02%	$44.6M	2.03M	+1,268,875	+167%	$21.97	Q3 2019
6/30/2019	0.01%	+0.01%	$14.6M	761K	+761,153	NEW	$19.15	Q2 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.